N. E. Gefen

Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma

Danit Lebanony, Hila Benjamin, Shlomit Gilad et al. · Journal of Clinical Oncology · 2009 · 407 citations · Full text

Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53

N. E. Gefen, Vera Binder, Markéta Žaliová et al. · Leukemia · 2009 · 107 citations · Full text

Cancer Research, Confers Survival Advantage, Oncology +12

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs

Eyal Greenberg, Liat Hershkovitz, Orit Itzhaki et al. · PLoS ONE · 2011 · 86 citations · Full text

Medicine, Cancer Aggressive Features, Melanoma +14

Identification of differentially expressed mRNA transcripts in drug-resistant versus parental human melanoma cell lines.

Nikola Tanić, G. Brkić, Bogomir Dimitrijević et al. · PubMed · 2006 · 30 citations

Acquired resistance to 6-thioguanine in melanoma cells involves the repair enzyme O⁶- methylguanine-DNA methyltransferase (MGMT).

N. E. Gefen, G. Brkić, Dalia Galron et al. · Cancer Biology & Therapy · 2010 · 12 citations · Full text